Development of Better-Quality Assay Method for the Citric Acid and Sodium Citrate in Ophthalmic/Oral Solutions and Their Application to Deformulation Studies
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52437#.VJi-icCAM4
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52437#.VJi-icCAM4
There were several techniques determined for the
analysis of citrate and citric acid mixtures in the pharmaceutical
dosage forms. Titration methods, photometric and ion chromatographic
methods were used for their determination. These methods will restrict
too many factors where the accurate quantification of citrate and citric
acid is extremely challenging. Citric acid is the natural flavor used
as a preservative for many pharmaceutical applications. Deformulation
techniques used for the manufacturing of generic drugs require authentic
data for their regulatory submissions. Simple accurate and reproducible
validated method developed for the determination of citric acid and
sodium citrate by titration followed by HPLC analysis. Free citric acid
was determined by the titration method and total citric acid was
determined by HPLC analysis. After subtracting the free citric acid from
total citric acid content, citric acid present in the sodium citrate
content was determined. Sodium citrate content was determined by
applying sodium correction factor to the subtracted value of the citric
acid. The results met all the validation parameters and the method was
successfully measured the amount of citric acid and sodium citrate in
the marketed ophthalmic/oral solutions.
KEYWORDS
Cite this paper
Hotha, K. , Patel, T. , Roychowdhury, S. and
Subramanian, V. (2014) Development of Better-Quality Assay Method for
the Citric Acid and Sodium Citrate in Ophthalmic/Oral Solutions and
Their Application to Deformulation Studies. American Journal of Analytical Chemistry, 5, 1249-1260. doi: 10.4236/ajac.2014.517131.
| [1] |
INCHEM Chemical Safety Information for Intergovernmental Organization. http://www.inchem.org/documents/cicads/cicads/cicad26.htm#SubSectionNumber:5.1.1 |
| [2] | US FDA (2007) Food Contamination and Adulteration: Data on Benzene in Soft Drinks and Other Beverages Data through May 16, 2007. |
| [3] | FAO/WHO (2002) Food and Agriculture Organization of the United Nations and World Health Organization. Human Vitamin and Mineral Requirements, Rome. |
| [4] |
Bhattacharyya, L. and Rohrer,
J.S. (2012) Applications of Ion Chromatography for Pharmaceutical and
Biological Products, First Edition. John Wiley & Sons, Inc.,
Hoboken. http://dx.doi.org/10.1002/9781118147009 |
| [5] |
Destandau, E., Vial, J., Jardy,
A., Hennion, M. C., Bonnet, D. and Lancelin, P. (2005) Development and
Validation of a Reversed-Phase Liquid Chromatography Method for the
Quantitative Determination of Carboxylic Acids in Industrial Reaction
Mixtures. Journal of Chromatography A, 1088, 49-56. http://dx.doi.org/10.1016/j.chroma.2005.01.002 |
| [6] | The United States Pharmacopeia (2006) Assay for Citric Acid/Citrate and Phosphate. In The United States Pharmacopeia, USP37. United Sates Pharmacopeia Convention, Rockville, 2565. |
| [7] |
Chalgeri, A. and Tan, H.I.S.
(1996) Indirect Photometric Detection for the Determination of Citrate
in Pharmaceutical Matrices by Ion Chromatography. Journal of
Pharmaceutical and Biomedical Analysis, 14, 835-844. http://dx.doi.org/10.1016/0731-7085(96)01731-1 |
| [8] |
Karmarkar, S., Koberda, M.,
Monami, J., Kotecki, D. and Garber, R. (2004) Validated Ion-Exclusion
Chromatographic Method for Citrate and Acetate in Medical Fluids.
Journal of Chromatography A, 1039, 147-153. http://dx.doi.org/10.1016/j.chroma.2003.11.057 |
| [9] |
Debora, B.M., Rohrer, J.S. and
Bhattacharyya, L. (2004) Development and Validation of an Assay for
Citric Acid/Citrate and Phosphate in Pharmaceutical Dosage Forms Using
Ionchromatography with Suppressed Conductivity Detection. Journal of
Pharmaceutical and Biomedical Analysis, 36, 517-524. http://dx.doi.org/10.1016/j.jpba.2004.07.003 |
| [10] |
Tan, H.S., McKibben, D.M. and
Glasser, A.C. (1981) Improved Assay for Mixtures of Citrate and Citric
Acid in Systemic Alkalizer Solutions. Journal of Pharmaceutical
Sciences, 70, 693-695. http://dx.doi.org/10.1002/jps.2600700634 |
| [11] |
Jenke, D., Sadain, S., Nunez, K.
and Byrne, F. (2007) Performance Characteristics of an Ion
Chromatographic Method for the Quantitation of Citrate and Phosphate in
Pharmaceutical Solutions. Journal of Chromatographic Science, 45, 50-56.
http://dx.doi.org/10.1093/chromsci/45.1.50 |
| [12] |
Chen, Q., Mou, S., Liu, K.,
Yang, Z., and Ni, Z. (1997) Separation and Determination of Four
Artificial Sweeteners and Citric Acid by High Performance Anion Exchange
Chromatography. Journal of Chromatography A, 771, 135-143. http://dx.doi.org/10.1016/S0021-9673(97)00067-8 |
| [13] |
Jenke, D.R. (1988) Quantitation
of Oxalate and Citrate by Ion Chromatography with a Buffered, Strong
Acid Eluent. Journal of Chromatography A, 437, 231-237. http://dx.doi.org/10.1016/S0021-9673(00)90386-8 |
| [14] | Dionex Corporation (2004) Application Note 164 Assay for Citrate and Phosphate in Pharmaceutical Formulations Using Ion Chromatography. Dionex Corporation, Sunnyvale. |
| [15] |
Fontannaz, P., Kilinc, T. and
Heudi, O. (2006) HPLC-UV Determination of Total Vitamin C in a Wide
Range of Fortified Food Products. Food Chemistry, 94, 626-631. http://dx.doi.org/10.1016/j.foodchem.2005.02.012 |
| [16] | Budziszewski, A. (1969) The Use of Ion Exchange for the Quantitative Assay of Mixtures of Citrate and Citric Acid. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 17, 149-152. |
| [17] |
Hotha, K.K., Reddy, S.P.K.,
Raju, V.K. and Ravindranath, L.K. (2013) Forced Degradation Studies:
Practical Approach-Overview of Regulatory Guidance and Literature for
the Drug Products and Drug Substances. International Research Journal of
Pharmacy, 4, 78-85. http://dx.doi.org/10.7897/2230-8407.04517 |
| [18] | ICH Q2 (R1) (2005) Validation of Analytical Procedures: Text and Methodology. |
| [19] | ICH Q1A (R2) (2000) Stability Testing of New Drug Substances and Products. |
| [20] | ICH Guideline Q3A (R) (2002) Impurities in New Drug Substances. eww141223lx |
评论
发表评论